Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences

Theme
"Don’t let Parkinson’s defines Human life"
- Parkinson's 2019

Welcome Message


Good Day!!

Parkinson’s 2019 Welcomes you all!!

On behalf of Conference Organizing Committee, we take a great pride in welcoming all the attendees for our International Conference on Parkinson’s, Huntington’s and Movement Disorder at Frankfurt Germany during April 17-18, 2019.  This conference will deliver new ideas, convictions, strategies and tactics where no conference will offer an impressive roaster of Keynote speakers, quality attendees, and compelling content. The various thematic sessions will be discussed at this conference, we welcome all of you to attend the conference.

This is an excellent opportunity for the delegates from various Universities and Institutes to interact with the world class Scientists. The interested participants can confirm their participation by registering for the Parkinson's 2019 along with your colleagues. This Conference will provide an excellent platform for the exchange of ideas and authoritative views by leading scientists as well as business leaders and investors in this exciting field.

Meet and Explore at Germany!!

 

Best Regards,

Organizing Committee

Parkinson’s 2019

About

Every year we host interdisciplinary international conferences worldwide on cutting-edge basic and applied research in life sciences, Pharma, medicine, healthcare and nursing delivered by the best talents in industry and academia. Our conferences are oriented to drive the scientific community at large, facilitating access to the newest technical and scientific achievements and to shape future research directions through the publication of applied and theoretical research findings of the highest quality.

We take the honor to welcome all the Healthcare professionals, company’s, research centers and laboratories belonging to the field of Neuroscience and Neurodegenerative disorders towards the International Conference on Parkinson’sHuntington’s and Movement Disorder at Frankfurt, Germany during April 17-18, 2019.

 

Why to Attend?

Parkinson’s 2019 are the leading meeting dedicated to Neurologists and Neurosurgeons researchers with the theme “Don’t let Parkinson’s defines Human life” Goal of Parkinson’s 2019 is to deliver an outstanding program for exchange of ideas and authoritative views by leading scientists which covers the entire spectrum of research in Parkinson’s, Huntington’s disease and Movement disorders and share the cross-cultural experiences of various treatment procedures.

We strive to make Parkinson’s 2019 a success, with your support and high-quality talks from Parkinson’s Huntington’s and Movement Disorder. During the conference, we assure you that you will experience the world class facilities and hospitality.


Scientific Sessions

Session onParkinson’s Disease

Parkinson’s Disease is a chronic and progressive disease of the nervous system and it became worse over time. It is the second most common neurological disorder. In ordinary Conditions, nerve cells exhibit in cerebrum and delivers a neurotransmitter called dopamine that oversees a development, feelings, and co-appointment yet because of unhealthy individual dopamine creation, hence the individual end up with control the development ordinarily. In Germany, has a lifetime prevalence of between 0.1 and 0.3% of the population.

Related: Parkinson’s Conference | Parkinson’s Disease Conference | Parkinson’s Congress | Movement Disorder Conferences | Neuroscience Conferences | Neurology  Conferences

Related Conferences:

World Congress on Parkinson’s and Movement Disorders, July 23-24, 2019 at Berlin, Germany | 5th Global Experts Meeting on Parkinson’s, Huntington’s & Movement Disorders, May 08-09, 2019, at Tokyo, Japan | 5th World Parkinson Congress, June 4-7,2019, at Kyoto, Japan | 5th International Conference on Parkinson’s disease and Movement Disorders, October 19-20, 2018, at New York, USA | Movement Disorders in Children and Young Adults, November 22-23, 2018, at Groningen, Netherlands

Related Association and Societies:

American Academy of NeurologyMovement Disorders SocietyThe International Parkinson and Movement Disorder Society;  Canadian Movement Disorders GroupUK Parkinson’s Action Network;  European Neurological SocietyEuropean Parkinson’s Disease AssociationDanish Movement Disorder SocietyItalian Society for the study of Parkinson DiseaseExtrapyramidal Diseases and DementiaMovement Disorder Society of AustraliaParkinson’s Disease and Movement Disorders Society of India; Australian Parkinson’s Disease SocietyMovement Disorder Society of Japan

 

Session onEpidemiology of Parkinson’s disease

Parkinson’s is one of the well-known age connected neurodegenerative disorder, in return simply to Alzheimer's disease.  There are approximately seven Million individuals affected with Parkinson’s globally. Several studies and theories are considering the danger factors and the protecting measures for the onset of the Parkinson, though the results were imperfect and foreseeable. The neuroepidemiology of PD is very complex with susceptibility genes and several modifiable risk factors that can increase and others that can mitigate risks and outcomes.

Related: Parkinson’s Conference | Parkinson’s Disease Conference | Parkinson’s Congress | Movement Disorder Conferences | Neuroscience Conferences | Neurology  Conferences

Related Conferences:

World Congress on Parkinson’s and Movement Disorders, July 23-24, 2019 at Berlin, Germany | 5th Global Experts Meeting on Parkinson’s, Huntington’s & Movement Disorders, May 08-09, 2019, at Tokyo, Japan | 5th World Parkinson Congress, June 4-7,2019, at Kyoto, Japan | 5th International Conference on Parkinson’s disease and Movement Disorders, October 19-20, 2018, at New York, USA | Movement Disorders in Children and Young Adults, November 22-23, 2018, at Groningen, Netherlands

Related Association and Societies:

American Academy of NeurologyMovement Disorders SocietyThe International Parkinson and Movement Disorder Society;  Canadian Movement Disorders GroupUK Parkinson’s Action Network;  European Neurological SocietyEuropean Parkinson’s Disease AssociationDanish Movement Disorder SocietyItalian Society for the study of Parkinson DiseaseExtrapyramidal Diseases and DementiaMovement Disorder Society of AustraliaParkinson’s Disease and Movement Disorders Society of India; Australian Parkinson’s Disease SocietyMovement Disorder Society of Japan

 

Session onDiagnosis of Parkinson’s Disease

The identification of PD is difficult in earlier stages, it goes on at the end the result is not obtained. There is no direct treatment for PD and there is no biopsy reports or scan reports that confirm the diagnosis. At present, there is no cure for PD. Medication is given in 3 stages: Initial stage includes the drug called Levodopa, which increase the monoamine neurotransmitter in the brain, the second stage shows less severe PD symptoms and the third stage will help to manage the non-motor symptoms as well as depression. Magnetic Resonance Imaging and Computed Tomogram are used by many physicians to find out other relating Parkinson’s diseases such as encephalitis, Tumours, Hydrocephalus. Dopamine level release and activity of the brain can easily detect using PET and SPECT examining.

Related: Parkinson’s Conference | Parkinson’s Disease Conference | Parkinson’s Congress | Movement Disorder Conferences | Neuroscience Conferences | Neurology  Conferences

Related Conferences:

World Congress on Parkinson’s and Movement Disorders, July 23-24, 2019 at Berlin, Germany | 5th Global Experts Meeting on Parkinson’s, Huntington’s & Movement Disorders, May 08-09, 2019, at Tokyo, Japan | 5th World Parkinson Congress, June 4-7,2019, at Kyoto, Japan | 5th International Conference on Parkinson’s disease and Movement Disorders, October 19-20, 2018, at New York, USA | Movement Disorders in Children and Young Adults, November 22-23, 2018, at Groningen, Netherlands

Related Association and Societies:

American Academy of NeurologyMovement Disorders SocietyThe International Parkinson and Movement Disorder Society;  Canadian Movement Disorders GroupUK Parkinson’s Action Network;  European Neurological SocietyEuropean Parkinson’s Disease AssociationDanish Movement Disorder SocietyItalian Society for the study of Parkinson DiseaseExtrapyramidal Diseases and DementiaMovement Disorder Society of AustraliaParkinson’s Disease and Movement Disorders Society of India; Australian Parkinson’s Disease SocietyMovement Disorder Society of Japan

 

Session onInsights and therapeutics: Parkinson’s disease

The introduction about Levodopa and the demonstration that dopamine loss is the key pathological feature of PD have revolutionized the field of PD therapeutics. In most cases of Parkinson’s disease, protein deposits called Lewy Bodies. It is unclear whether Lewy bodies play an important role in killing nerve cells or just part of the cells which are responsible to the Parkinson’s disease. Nearly 15 percent of people with PD have motor symptoms that are not controlled with levodopa. A group of drugs that act directly on dopaminergic reports called dopamine against is used as adjuncts to levodopa in the treatment of PD.

Related: Parkinson’s Conference | Parkinson’s Disease Conference | Parkinson’s Congress | Movement Disorder Conferences | Neuroscience Conferences | Neurology  Conferences

Related Conferences:

World Congress on Parkinson’s and Movement Disorders, July 23-24, 2019 at Berlin, Germany | 5th Global Experts Meeting on Parkinson’s, Huntington’s & Movement Disorders, May 08-09, 2019, at Tokyo, Japan | 5th World Parkinson Congress, June 4-7,2019, at Kyoto, Japan | 5th International Conference on Parkinson’s disease and Movement Disorders, October 19-20, 2018, at New York, USA | Movement Disorders in Children and Young Adults, November 22-23, 2018, at Groningen, Netherlands

Related Association and Societies:

American Academy of NeurologyMovement Disorders SocietyThe International Parkinson and Movement Disorder Society;  Canadian Movement Disorders GroupUK Parkinson’s Action Network;  European Neurological SocietyEuropean Parkinson’s Disease AssociationDanish Movement Disorder SocietyItalian Society for the study of Parkinson DiseaseExtrapyramidal Diseases and DementiaMovement Disorder Society of AustraliaParkinson’s Disease and Movement Disorders Society of India; Australian Parkinson’s Disease SocietyMovement Disorder Society of Japan

 

Session onParkinson’s Disease complications

Parkinson’s disease is not a life-threatening condition. With time, the illness will bring more problems with speech, movement, and brain functioning. Parkinson’s disease is usually accompanied by additional problems, which may be cured, and they are thinking difficulties, swallowing, depression and emotional changes, sleep difficulties, constipation, blood pressure changes, fatigue, pain, and some complications are Insomnia, Urinary Incontinence, Paraesthesia.

Related: Parkinson’s Conference | Parkinson’s Disease Conference | Parkinson’s Congress | Movement Disorder Conferences | Neuroscience Conferences | Neurology  Conferences

Related Conferences:

World Congress on Parkinson’s and Movement Disorders, July 23-24, 2019 at Berlin, Germany | 5th Global Experts Meeting on Parkinson’s, Huntington’s & Movement Disorders, May 08-09, 2019, at Tokyo, Japan | 5th World Parkinson Congress, June 4-7,2019, at Kyoto, Japan | 5th International Conference on Parkinson’s disease and Movement Disorders, October 19-20, 2018, at New York, USA | Movement Disorders in Children and Young Adults, November 22-23, 2018, at Groningen, Netherlands

Related Association and Societies:

American Academy of NeurologyMovement Disorders SocietyThe International Parkinson and Movement Disorder Society;  Canadian Movement Disorders GroupUK Parkinson’s Action Network;  European Neurological SocietyEuropean Parkinson’s Disease AssociationDanish Movement Disorder SocietyItalian Society for the study of Parkinson DiseaseExtrapyramidal Diseases and DementiaMovement Disorder Society of AustraliaParkinson’s Disease and Movement Disorders Society of India; Australian Parkinson’s Disease SocietyMovement Disorder Society of Japan

 

Session onPathophysiology and Pharmacology

Parkinson’s disease is originated from the gradual loss of cells in the substantia nigra of the brain. This is mainly responsible for the assembly of neurotransmitter. Dopamine is a neurotransmitter which transmits signals between two regions of the brain to coordinate activities like the movement of limbs. If there is a deficiency in dopamine production results in loss of coordination and end up with the symptoms of Parkinson’s Disease. The disease progresses, various areas of the brain and nervous system degenerate to boot inflicting a lot of movement disorder.

Related: Parkinson’s Conference | Parkinson’s Disease Conference | Parkinson’s Congress | Movement Disorder Conferences | Neuroscience Conferences | Neurology  Conferences

Related Conferences:

World Congress on Parkinson’s and Movement Disorders, July 23-24, 2019 at Berlin, Germany | 5th Global Experts Meeting on Parkinson’s, Huntington’s & Movement Disorders, May 08-09, 2019, at Tokyo, Japan | 5th World Parkinson Congress, June 4-7,2019, at Kyoto, Japan | 5th International Conference on Parkinson’s disease and Movement Disorders, October 19-20, 2018, at New York, USA | Movement Disorders in Children and Young Adults, November 22-23, 2018, at Groningen, Netherlands

Related Association and Societies:

American Academy of NeurologyMovement Disorders SocietyThe International Parkinson and Movement Disorder Society;  Canadian Movement Disorders GroupUK Parkinson’s Action Network;  European Neurological SocietyEuropean Parkinson’s Disease AssociationDanish Movement Disorder SocietyItalian Society for the study of Parkinson DiseaseExtrapyramidal Diseases and DementiaMovement Disorder Society of AustraliaParkinson’s Disease and Movement Disorders Society of India; Australian Parkinson’s Disease SocietyMovement Disorder Society of Japan

 

Session onClinical Trials in Parkinsonism

To develop a drug or treatment for Parkinson’s disease observational study is being conducted by a scientist in a laboratory to provide patients with a better life. Clinical trials are performed to slow down the rate of suffering and reduce the symptoms. There is no cure for PD as far, but researchers improved more treatment. Trails help to reduce the risk factors

Trails are the best way to find out whether a new treatment

    is safe,                                                                                                                                                                               

    is a benefit to patients,                                                                                                                                                                

    is more effective,                                                                                                                                                            

    is that improving the quality of life with PD

Clinical research is an expensive process which requires strong financial support. This comes from a range of sponsors including the pharmaceutical industries, Governments, Researchers, and Organisations.

Related: Parkinson’s Conference | Parkinson’s Disease Conference | Parkinson’s Congress | Movement Disorder Conferences | Neuroscience Conferences | Neurology  Conferences

Related Conferences:

World Congress on Parkinson’s and Movement Disorders, July 23-24, 2019 at Berlin, Germany | 5th Global Experts Meeting on Parkinson’s, Huntington’s & Movement Disorders, May 08-09, 2019, at Tokyo, Japan | 5th World Parkinson Congress, June 4-7,2019, at Kyoto, Japan | 5th International Conference on Parkinson’s disease and Movement Disorders, October 19-20, 2018, at New York, USA | Movement Disorders in Children and Young Adults, November 22-23, 2018, at Groningen, Netherlands

Related Association and Societies:

American Academy of NeurologyMovement Disorders SocietyThe International Parkinson and Movement Disorder Society;  Canadian Movement Disorders GroupUK Parkinson’s Action Network;  European Neurological SocietyEuropean Parkinson’s Disease AssociationDanish Movement Disorder SocietyItalian Society for the study of Parkinson DiseaseExtrapyramidal Diseases and DementiaMovement Disorder Society of AustraliaParkinson’s Disease and Movement Disorders Society of India; Australian Parkinson’s Disease SocietyMovement Disorder Society of Japan

 

Session onFree Radicals and Aging in Parkinson’s

Free radicles have both beneficial and baleful effect on human body parts. Oxidative stress is known to cause many neurological disorders such as Alzheimer’s, Parkinson’s and Amyotrophic Lateral Sclerosis. With oldness, there is a typical failure of the dopamine-producing neurons. In some of the rare situation’s symptoms are seen in children and terms is referred to as Juvenile Parkinsonism.

Related: Parkinson’s Conference | Parkinson’s Disease Conference | Parkinson’s Congress | Movement Disorder Conferences | Neuroscience Conferences | Neurology  Conferences

Related Conferences:

World Congress on Parkinson’s and Movement Disorders, July 23-24, 2019 at Berlin, Germany | 5th Global Experts Meeting on Parkinson’s, Huntington’s & Movement Disorders, May 08-09, 2019, at Tokyo, Japan | 5th World Parkinson Congress, June 4-7,2019, at Kyoto, Japan | 5th International Conference on Parkinson’s disease and Movement Disorders, October 19-20, 2018, at New York, USA | Movement Disorders in Children and Young Adults, November 22-23, 2018, at Groningen, Netherlands

Related Association and Societies:

American Academy of NeurologyMovement Disorders SocietyThe International Parkinson and Movement Disorder Society;  Canadian Movement Disorders GroupUK Parkinson’s Action Network;  European Neurological SocietyEuropean Parkinson’s Disease AssociationDanish Movement Disorder SocietyItalian Society for the study of Parkinson DiseaseExtrapyramidal Diseases and DementiaMovement Disorder Society of AustraliaParkinson’s Disease and Movement Disorders Society of India; Australian Parkinson’s Disease SocietyMovement Disorder Society of Japan

 

Session onManaging life with Parkinson’s disease

It is important to develop a PD management plan because it is a chronic disease. The individual should get practiced to maintain the stress levels and depression by daily communicating with close people, friends, colleagues. Patients can improve life by following Instructions given by the counselor. Managing life with PD includes building a healthcare team with proper Doctors, proper intake of medications, exercises, nutritional drink, and proper sleep.

Related: Parkinson’s Conference | Parkinson’s Disease Conference | Parkinson’s Congress | Movement Disorder Conferences | Neuroscience Conferences | Neurology  Conferences

Related Conferences:

World Congress on Parkinson’s and Movement Disorders, July 23-24, 2019 at Berlin, Germany | 5th Global Experts Meeting on Parkinson’s, Huntington’s & Movement Disorders, May 08-09, 2019, at Tokyo, Japan | 5th World Parkinson Congress, June 4-7,2019, at Kyoto, Japan | 5th International Conference on Parkinson’s disease and Movement Disorders, October 19-20, 2018, at New York, USA | Movement Disorders in Children and Young Adults, November 22-23, 2018, at Groningen, Netherlands

Related Association and Societies:

American Academy of NeurologyMovement Disorders SocietyThe International Parkinson and Movement Disorder Society;  Canadian Movement Disorders GroupUK Parkinson’s Action Network;  European Neurological SocietyEuropean Parkinson’s Disease AssociationDanish Movement Disorder SocietyItalian Society for the study of Parkinson DiseaseExtrapyramidal Diseases and DementiaMovement Disorder Society of AustraliaParkinson’s Disease and Movement Disorders Society of India; Australian Parkinson’s Disease SocietyMovement Disorder Society of Japan

 

Session onRisk Factors of Parkinson’s Disease

Risk factors for the PD mainly depend on age, hereditary, sex and exposure to toxins. The causes of the diseases are believed to be either genetic or environmental. Symptoms and progression of disease will not be the same among the suffering individuals but people with Parkinson’s are at a higher rate of developing related risks. Parkinson’s disease has a chance of creating mental ailment which can be mild or serious. It includes cognition, mood, behavior which are considered as major impairment when compared to normal populational. The common mood swings seen in the patients are despair, eagerness, indifference Melanoma, Neurogenic, Orthostatic Hypotension, Executive dysfunction, Orthostatic hypertension. Now a day’s Head Injury and Gene variation are in addition to an element of PD.

Related: Parkinson’s Conference | Parkinson’s Disease Conference | Parkinson’s Congress | Movement Disorder Conferences | Neuroscience Conferences | Neurology  Conferences

Related Conferences:

World Congress on Parkinson’s and Movement Disorders, July 23-24, 2019 at Berlin, Germany | 5th Global Experts Meeting on Parkinson’s, Huntington’s & Movement Disorders, May 08-09, 2019, at Tokyo, Japan | 5th World Parkinson Congress, June 4-7,2019, at Kyoto, Japan | 5th International Conference on Parkinson’s disease and Movement Disorders, October 19-20, 2018, at New York, USA | Movement Disorders in Children and Young Adults, November 22-23, 2018, at Groningen, Netherlands

Related Association and Societies:

American Academy of NeurologyMovement Disorders SocietyThe International Parkinson and Movement Disorder Society;  Canadian Movement Disorders GroupUK Parkinson’s Action Network;  European Neurological SocietyEuropean Parkinson’s Disease AssociationDanish Movement Disorder SocietyItalian Society for the study of Parkinson DiseaseExtrapyramidal Diseases and DementiaMovement Disorder Society of AustraliaParkinson’s Disease and Movement Disorders Society of India; Australian Parkinson’s Disease SocietyMovement Disorder Society of Japan

 

Session onHuntington’s Disease

Huntington’s disease (HD) is a fatal genetic disorder usually inherited from Parents and often many describe the symptoms of HD as having Parkinson’s and Alzheimer’s disease simultaneously. Symptoms usually appear between the ages of 30 to 50 and worsen over a 10 to 25 every year. The weak people tend to have pneumonia, Heart failure, and other complications. Every person who inherits the expanded HD gene will eventually develop the Huntington disease. Over a period, HD affects the individual’s ability to reason, walk and speak. In approximately 10% of cases have HD in children or adolescents. The symptoms of Juvenile HD are somewhat different than adult-onset HD and it includes Stiffness or awkward walking, increased clumsiness and changes in speech. The ability of learning skills may tend to decline, and the child may lose skills.

Related: Parkinson’s Conference | Parkinson’s Disease Conference | Parkinson’s Congress | Movement Disorder Conferences | Neuroscience Conferences | Neurology  Conferences

Related Conferences:

World Congress on Parkinson’s and Movement Disorders, July 23-24, 2019 at Berlin, Germany | 5th Global Experts Meeting on Parkinson’s, Huntington’s & Movement Disorders, May 08-09, 2019, at Tokyo, Japan | 5th World Parkinson Congress, June 4-7,2019, at Kyoto, Japan | 5th International Conference on Parkinson’s disease and Movement Disorders, October 19-20, 2018, at New York, USA | Movement Disorders in Children and Young Adults, November 22-23, 2018, at Groningen, Netherlands

Related Association and Societies:

American Academy of NeurologyMovement Disorders SocietyThe International Parkinson and Movement Disorder Society;  Canadian Movement Disorders GroupUK Parkinson’s Action Network;  European Neurological SocietyEuropean Parkinson’s Disease AssociationDanish Movement Disorder SocietyItalian Society for the study of Parkinson DiseaseExtrapyramidal Diseases and DementiaMovement Disorder Society of AustraliaParkinson’s Disease and Movement Disorders Society of India; Australian Parkinson’s Disease SocietyMovement Disorder Society of Japan

 

Session onBradykinesia

According to studies more than men, women were mostly affected by Bradykinesia. It is a reduced pace in bodily movements of a person. Parkinson’s has four key symptoms, in that Bradykinesia is one among them. Parkinson’s is also called "Idiopathic parkinsonism", meaning parkinsonism with no identifiable cause.

Related: Parkinson’s Conference | Parkinson’s Disease Conference | Parkinson’s Congress | Movement Disorder Conferences | Neuroscience Conferences | Neurology  Conferences

Related Conferences:

World Congress on Parkinson’s and Movement Disorders, July 23-24, 2019 at Berlin, Germany | 5th Global Experts Meeting on Parkinson’s, Huntington’s & Movement Disorders, May 08-09, 2019, at Tokyo, Japan | 5th World Parkinson Congress, June 4-7,2019, at Kyoto, Japan | 5th International Conference on Parkinson’s disease and Movement Disorders, October 19-20, 2018, at New York, USA | Movement Disorders in Children and Young Adults, November 22-23, 2018, at Groningen, Netherlands

Related Association and Societies:

American Academy of NeurologyMovement Disorders SocietyThe International Parkinson and Movement Disorder Society;  Canadian Movement Disorders GroupUK Parkinson’s Action Network;  European Neurological SocietyEuropean Parkinson’s Disease AssociationDanish Movement Disorder SocietyItalian Society for the study of Parkinson DiseaseExtrapyramidal Diseases and DementiaMovement Disorder Society of AustraliaParkinson’s Disease and Movement Disorders Society of India; Australian Parkinson’s Disease SocietyMovement Disorder Society of Japan

 

Session onAlzheimer’s Disease & Dementia

Alzheimer’s is caused by cerebrum cell demise and it is a neurological issue in which the demise of cerebrum cells causes memory misfortune and intellectual decrease. Dementia is a general form term for a decline in ability severe enough to interface with daily life. Alzheimer’s is the most common type of dementia. Memory loss is an example. The disease progress in different stages: Early, Moderate and Advanced stages. Early stage is Tremor, it is the first symptom. As it continues it will lead to Dementia in few cases. Some of the complications include Dementia of Alzheimer’s Disease, Treatment of Alzheimer’s Disease, Stroke related Dementia, Young onset Dementia.

Related: Parkinson’s Conference | Parkinson’s Disease Conference | Parkinson’s Congress | Movement Disorder Conferences | Neuroscience Conferences | Neurology  Conferences

Related Conferences:

World Congress on Parkinson’s and Movement Disorders, July 23-24, 2019 at Berlin, Germany | 5th Global Experts Meeting on Parkinson’s, Huntington’s & Movement Disorders, May 08-09, 2019, at Tokyo, Japan | 5th World Parkinson Congress, June 4-7,2019, at Kyoto, Japan | 5th International Conference on Parkinson’s disease and Movement Disorders, October 19-20, 2018, at New York, USA | Movement Disorders in Children and Young Adults, November 22-23, 2018, at Groningen, Netherlands

Related Association and Societies:

American Academy of NeurologyMovement Disorders SocietyThe International Parkinson and Movement Disorder Society;  Canadian Movement Disorders GroupUK Parkinson’s Action Network;  European Neurological SocietyEuropean Parkinson’s Disease AssociationDanish Movement Disorder SocietyItalian Society for the study of Parkinson DiseaseExtrapyramidal Diseases and DementiaMovement Disorder Society of AustraliaParkinson’s Disease and Movement Disorders Society of India; Australian Parkinson’s Disease SocietyMovement Disorder Society of Japan

 

Session onPediatric Movement disorders

It is a moderately new and developing field of child neurology. There are many genetic diseases which cause secondary movement disorder in childhood. Propels in pediatric movement disorder have been made by solidifying movement disorder definitions, growing the range of phenotypes, understanding genetic reasons for movement disorders, and thoroughly assessing treatment adequacy for normal movement disorder. The central nervous system typically implicated in disorders of movements are the basal and frontal cortex.

Related: Parkinson’s Conference | Parkinson’s Disease Conference | Parkinson’s Congress | Movement Disorder Conferences | Neuroscience Conferences | Neurology  Conferences

Related Conferences:

World Congress on Parkinson’s and Movement Disorders, July 23-24, 2019 at Berlin, Germany | 5th Global Experts Meeting on Parkinson’s, Huntington’s & Movement Disorders, May 08-09, 2019, at Tokyo, Japan | 5th World Parkinson Congress, June 4-7,2019, at Kyoto, Japan | 5th International Conference on Parkinson’s disease and Movement Disorders, October 19-20, 2018, at New York, USA | Movement Disorders in Children and Young Adults, November 22-23, 2018, at Groningen, Netherlands

Related Association and Societies:

American Academy of NeurologyMovement Disorders SocietyThe International Parkinson and Movement Disorder Society;  Canadian Movement Disorders GroupUK Parkinson’s Action Network;  European Neurological SocietyEuropean Parkinson’s Disease AssociationDanish Movement Disorder SocietyItalian Society for the study of Parkinson DiseaseExtrapyramidal Diseases and DementiaMovement Disorder Society of AustraliaParkinson’s Disease and Movement Disorders Society of India; Australian Parkinson’s Disease SocietyMovement Disorder Society of Japan

 

Session onNeuromuscular Disorders and Neural transplantation  

Neurons are responsible for communication when they cannot produce signals communication between nervous system breaks and result in neuromuscular disorders. Some of them are ALS, Multiple sclerosis, Alzheimer’s disease, Spinal Muscular Atrophy. Neural transplantation is the transplantation of nerve cells, tissues into the brain and spinal cord. The cell replacement for PD is based on two hypothesis- firstly the early symptoms of PD are dependent on the loss of the dopaminergic neurons in the nigrostriatal pathways and secondly the dopaminergic neurons are gathered into dopamine deficient striatum can replace those neurons which has been lost during the disease process and can reverse some extent of the major symptoms of PD. Some of the therapies are Neural Grafting, Transplantation therapy, Cell Transplantation, Rebuilding of Dopamine Circuit

Related: Parkinson’s Conference | Parkinson’s Disease Conference | Parkinson’s Congress | Movement Disorder Conferences | Neuroscience Conferences | Neurology  Conferences

Related Conferences:

World Congress on Parkinson’s and Movement Disorders, July 23-24, 2019 at Berlin, Germany | 5th Global Experts Meeting on Parkinson’s, Huntington’s & Movement Disorders, May 08-09, 2019, at Tokyo, Japan | 5th World Parkinson Congress, June 4-7,2019, at Kyoto, Japan | 5th International Conference on Parkinson’s disease and Movement Disorders, October 19-20, 2018, at New York, USA | Movement Disorders in Children and Young Adults, November 22-23, 2018, at Groningen, Netherlands

Related Association and Societies:

American Academy of NeurologyMovement Disorders SocietyThe International Parkinson and Movement Disorder Society;  Canadian Movement Disorders GroupUK Parkinson’s Action Network;  European Neurological SocietyEuropean Parkinson’s Disease AssociationDanish Movement Disorder SocietyItalian Society for the study of Parkinson DiseaseExtrapyramidal Diseases and DementiaMovement Disorder Society of AustraliaParkinson’s Disease and Movement Disorders Society of India; Australian Parkinson’s Disease SocietyMovement Disorder Society of Japan

 

Session onNeurosurgery

Presently Deep brain stimulator is widely recommended for improving people suffering from Parkinson’s disease. There will be no effect by using DBS to healthy brain tissue by terminating nerve cells. Instead of that, the procedure blocks electrical signals from targeted areas in the brain.

Related: Parkinson’s Conference | Parkinson’s Disease Conference | Parkinson’s Congress | Movement Disorder Conferences | Neuroscience Conferences | Neurology  Conferences

Related Conferences:

World Congress on Parkinson’s and Movement Disorders, July 23-24, 2019 at Berlin, Germany | 5th Global Experts Meeting on Parkinson’s, Huntington’s & Movement Disorders, May 08-09, 2019, at Tokyo, Japan | 5th World Parkinson Congress, June 4-7,2019, at Kyoto, Japan | 5th International Conference on Parkinson’s disease and Movement Disorders, October 19-20, 2018, at New York, USA | Movement Disorders in Children and Young Adults, November 22-23, 2018, at Groningen, Netherlands

Related Association and Societies:

American Academy of NeurologyMovement Disorders SocietyThe International Parkinson and Movement Disorder Society;  Canadian Movement Disorders GroupUK Parkinson’s Action Network;  European Neurological SocietyEuropean Parkinson’s Disease AssociationDanish Movement Disorder SocietyItalian Society for the study of Parkinson DiseaseExtrapyramidal Diseases and DementiaMovement Disorder Society of AustraliaParkinson’s Disease and Movement Disorders Society of India; Australian Parkinson’s Disease SocietyMovement Disorder Society of Japan

 

Session on: Novel Therapeutics

The most used drug for treating Parkinson’s disease is Levodopa which has a higher frequency to develop motor fluctuations and results in L-dopa induced dyskinesia (LID). Researchers propose novel ideas to treat Parkinson’s disease to decrease the risk of causing side effects, the frequency of dyskinesia, to treat cognitive disorders such as Anxiety and depression.

Related: Parkinson’s Conference | Parkinson’s Disease Conference | Parkinson’s Congress | Movement Disorder Conferences | Neuroscience Conferences | Neurology  Conferences

Related Conferences:

World Congress on Parkinson’s and Movement Disorders, July 23-24, 2019 at Berlin, Germany | 5th Global Experts Meeting on Parkinson’s, Huntington’s & Movement Disorders, May 08-09, 2019, at Tokyo, Japan | 5th World Parkinson Congress, June 4-7,2019, at Kyoto, Japan | 5th International Conference on Parkinson’s disease and Movement Disorders, October 19-20, 2018, at New York, USA | Movement Disorders in Children and Young Adults, November 22-23, 2018, at Groningen, Netherlands

Related Association and Societies:

American Academy of NeurologyMovement Disorders SocietyThe International Parkinson and Movement Disorder Society;  Canadian Movement Disorders GroupUK Parkinson’s Action Network;  European Neurological SocietyEuropean Parkinson’s Disease AssociationDanish Movement Disorder SocietyItalian Society for the study of Parkinson DiseaseExtrapyramidal Diseases and DementiaMovement Disorder Society of AustraliaParkinson’s Disease and Movement Disorders Society of India; Australian Parkinson’s Disease SocietyMovement Disorder Society of Japan

Market Analysis

Theme: Don’t let Parkinson’s defines Human life

Parkinson’s disease market is set to expand from $2.2 billion in 2014 to $3.3 billion by 2021, at a moderate Compound Annual Growth Rate (CAGR) of 5.8 percent, game-changing treatments will not be available for the future, according to business intelligence provider GBI Research. There are approximately 10 million individuals experiencing Parkinson's infection all around the world. Parkinson's, as far it has a higher recurrence in the created nations.

In Worldwide, it is estimated that 6.3 million people have PD with no differentiation for race and culture. The age of onset is usually over 60-65, but it is estimated that one in ten are diagnosed before the age of 50, and it can affect people in their 40’s and younger.

According to available statistics, 2 million people in Europe have Parkinson’s, which approximates to:

260,000 in Germany

200,000 in Italy

150,000 in Spain

120,000 in UK

117,000 in France.

PD makes the second most common neurodegenerative disorder, that is it equates to a rate of more than 1 per 1000 people in Europe.

It is difficult to tell how common Huntington’s Disease HD is in a population across the world. In Western Countries, it’s estimated that about five to nine people per 100,000 are affected by HD. A high population of HD has also been found in the Lake Maracaibo region of Venezuela where the prevalence of HD is about 700 per 100,000.

For more details please visit: parkinsons.alliedacademies.com

Conference Highlights:

Parkinson’s Disease

Epidemiology of Parkinson’s disease

Diagnosis of Parkinson's disease

Insights and therapeutics: Parkinson’s disease

Parkinson's disease Complications

Pathophysiology and Pharmacology

Clinical trials in parkinsonism

Free radicals and aging in parkinsonism

Managing life with Parkinson's disease

Risk factors of Parkinson’s disease

Huntington’s Disease

Bradykinesia

Alzheimer’s disease and Dementia

Pediatric movement disorder

Neuromuscular Disorder

Neurosurgery

Novel Therapeutics

Target Audience

Neurologists, Psychiatrists, Psychologists, Neurosurgeon, Director, Industries, Delegates, Clinical Specialists, Physicians, Neuroscientists,  Community members, Lectures and Students from various Academics, Professors, Researchers, Scientists, Therapists.

Major Associations around the Globe

National Parkinson Foundation

American Parkinson Disease Association (APDA)

Parkinson’s disease Foundation

Movement Disorder Society of Australia

Parkinson's Unity Walk

Movement Disorder Society of Japan

Moroccan Neurological Society Movement Disorders Group

Italian Society for the Study of Parkinson Disease, Extrapyramidal Diseases, and Dementia

Ecuador Movement Disorders Group

Austrian Parkinson's Disease Society

Danish Movement Disorder Society

Top universities 500 globally working in the field of Parkinson's Disease

University of Bath

The University of Queensland

University of Bristol

University of Cambridge

The Imperial College of Science and Medicine

Duke University

University of Milan

Karolinska Institute

University of Hamburg

The University of Edinburgh

University of Munich

University of Rochester

University of Zurich

Leiden University

University of Bristol

University of Helsinki

Uppsala University

University of Freiburg

University of Frankfurt



Organizing Committee
OCM Member
Dr. A. Q. Rana
Director, Parkinson's Clinic of Eastern Toronto & Movement Disorders Centre
Parkinson's Clinic of Eastern Toronto & Movement Disorders Centre
Toronto, Canada
OCM Member
Omar El-Agnaf
Director of Neurological Disorders Center (QBRI) and Professor at Hamid Bin Khalifa University (HBKU)
Hamad Bin Khalifa University (HBKU)
Al Luqta St, Qatar
OCM Member
Prof. Dr. Cynthia Bedeschi
Doctor and Master in Neuroscience and Behavior - USP Specialist in Physiotherapy in Neurology - USP
Universidade Paulista - UNIP
Sao Paulo, Brazil

To Collaborate Scientific Professionals around the World

Conference Date April 17-18, 2019
Speaker Oppurtunity
Poster Oppurtunity Available
e-Poster Oppurtunity Available
Venue
&
Hospitality

Hilda Cangelosi ~ Director of Sales

Hilton New York JFK Airport Hotel

144-02 135th Avenue | Jamaica, New York 11436 | USA

Tel +1 718-269-3028

Fax +1 718-269-2691

Join The Discussion

Contact Desk

Drop us a mail for program enquiry

Lyra Greyson

parkinsons@alliedconferences.org

+44 20 3769 1755 Ext:5038

Sponser/Exhibiting/advertising

Sangeeta Giri

sponsoraac@alliedacademies.com

+44 20 3769 1755 Ext:5038

General queries

Jaquelin Clare

parkinsons@alliedconferences.org

+44 20 3769 1755 Ext:5038

Media Partners

Allied Academies Global Conference Directory

Mail us at

Drop us a mail for program enquiry
parkinsons@alliedconferences.org
Sponser/Exhibiting/advertising
sponsoraac@alliedacademies.com
General queries
parkinsons@alliedconferences.org
More details about sponsorship:sponsors@alliedacademies.com

Highlights from last year's Convention

Copyright © 2018-2019 Allied Academies, All Rights Reserved.